Comparative Evaluation of Knowledge, Attitudes and Hesitancies Related to Four Different Types of Vaccines: Smallpox, Influenza, Tetanus Versus Covid-19 Vaccines
Abstract
Background and Purpose: The Covid-19 pandemic has brought the anti-vaccination problem back to the agenda. In this study, knowledge, attitudes and hesitancies related to four different types of well-publicized vaccines (smallpox, influenza, tetanus vs Covid-19) were comparatively evaluated to provide a unique understanding of vaccine hesitancy in general and distinctively for Covid-19.
Methods: A cross-sectional study was conducted face-to-face among the university students. A 26-item questionnaire was designed to collect the data. The survey covered demographics and vaccine-related sections for each of four vaccines. Vaccine knowledge, attitudes/perceptions related to vaccine hesitancy were questioned in 4 sub-sections to receive participants answers for each vaccine. Obtained data were analyzed by biostatistical methods. Results: Covid-19 PCR positivity rate was 38.2% among the participants during study. General knowledge level score mean was 31.63/48 (65.89%) among the participants. General correct attitude score towards all vaccines mean was 70.78/104 (68.06%) among the participants. Participants have responded significantly different answers to Covid-19 vaccines in 14 of 22 questions/statements. New types of vaccines, logistics of these vaccines and severe side effects of vaccines were the parameters perceived significantly different for Covid-19 vaccines among others.
Conclusion: Our comparative analyzes have revealed that there are different points particularly for Covid-19 among others in the vaccine opposition seen in the Covid-19 pandemic.
Keywords
References
- 1. Kim YC, Dema B, Reyes-Sandoval A. 2020. COVID-19 vaccines: breaking record times to first-in-human trials. NPJ Vaccines 5:1–3.
- 2. Locht C. 2020. Vaccines against COVID-19. Anaesth Crit Care Pain Med. Elsevier. 3. Broniatowski DA, Quinn SC, Dredze M, Jamison AM. 2020. Vaccine communication as weaponized identity politics. Am J Public Health 110:617.
- 4. Organization WH. 2021. Infodemic management: an overview of infodemic management during COVID-19, January 2020–May 2021.
- 5. BAŞARAN A, Barış ÇİL. 2022. Vaccine Opposal in People Over 60 Years of Age in Mardin/Turkey–A Territory with Low Rate of Vaccination. Journal of Contemporary Medicine 12:81–85.
- 6. Orenstein WA, Ahmed R. 2017. Simply put: Vaccination saves lives. Proceedings of the National Academy of Sciences 114:4031–4033.
- 7. Ryan J, Malinga T. 2021. Interventions for vaccine hesitancy. Curr Opin Immunol 71:89–91.
- 8. Mohamed NA, Solehan HM, Mohd Rani MD, Ithnin M, Che Isahak CI. 2021. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey. PLoS One 16:e0256110-.
- 9. Jiang N, Wei B, Lin H, Wang Y, Chai S, Liu W. 2021. Nursing students’ attitudes, knowledge and willingness of to receive the coronavirus disease vaccine: A cross-sectional study. Nurse Educ Pract 55:103148.
- 10. Shen S (Cindy), Dubey V. 2019. Addressing vaccine hesitancy. Canadian Family Physician 65:175.
- 11. Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. 2021. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front Public Health 9.
- 12. Hudson A, Montelpare WJ. 2021. Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging. Int J Environ Res Public Health 18.
- 13. Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, Yousaf Z, Seboka BT, Ullah I, Lin C-Y, Pakpour AH. 2021. COVID-19 Vaccine Hesitancy in the United States: A Systematic Review. Front Public Health 9.
- 14. Kim J, Kim Y, Li Y. 2022. Source of information on COVID-19 vaccine and vaccine hesitancy among U.S. Medicare beneficiaries. J Am Geriatr Soc 70:677–680.
- 15. Anand P, Stahel VP. 2021. The safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg 15:20.
- 16. Donnelly SC. 2022. COVID-19 vaccine hesitancy after side effects to the first vaccine: what are our options? QJM: An International Journal of Medicine. Oxford University Press.
- 17. Paris C, Bénézit F, Geslin M, Polard E, Baldeyrou M, Turmel V, Tadié É, Garlantezec R, Tattevin P. 2021. COVID-19 vaccine hesitancy among healthcare workers. Infect Dis Now 51:484–487.
Abstract
References
- 1. Kim YC, Dema B, Reyes-Sandoval A. 2020. COVID-19 vaccines: breaking record times to first-in-human trials. NPJ Vaccines 5:1–3.
- 2. Locht C. 2020. Vaccines against COVID-19. Anaesth Crit Care Pain Med. Elsevier. 3. Broniatowski DA, Quinn SC, Dredze M, Jamison AM. 2020. Vaccine communication as weaponized identity politics. Am J Public Health 110:617.
- 4. Organization WH. 2021. Infodemic management: an overview of infodemic management during COVID-19, January 2020–May 2021.
- 5. BAŞARAN A, Barış ÇİL. 2022. Vaccine Opposal in People Over 60 Years of Age in Mardin/Turkey–A Territory with Low Rate of Vaccination. Journal of Contemporary Medicine 12:81–85.
- 6. Orenstein WA, Ahmed R. 2017. Simply put: Vaccination saves lives. Proceedings of the National Academy of Sciences 114:4031–4033.
- 7. Ryan J, Malinga T. 2021. Interventions for vaccine hesitancy. Curr Opin Immunol 71:89–91.
- 8. Mohamed NA, Solehan HM, Mohd Rani MD, Ithnin M, Che Isahak CI. 2021. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey. PLoS One 16:e0256110-.
- 9. Jiang N, Wei B, Lin H, Wang Y, Chai S, Liu W. 2021. Nursing students’ attitudes, knowledge and willingness of to receive the coronavirus disease vaccine: A cross-sectional study. Nurse Educ Pract 55:103148.
- 10. Shen S (Cindy), Dubey V. 2019. Addressing vaccine hesitancy. Canadian Family Physician 65:175.
- 11. Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. 2021. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front Public Health 9.
- 12. Hudson A, Montelpare WJ. 2021. Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging. Int J Environ Res Public Health 18.
- 13. Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, Yousaf Z, Seboka BT, Ullah I, Lin C-Y, Pakpour AH. 2021. COVID-19 Vaccine Hesitancy in the United States: A Systematic Review. Front Public Health 9.
- 14. Kim J, Kim Y, Li Y. 2022. Source of information on COVID-19 vaccine and vaccine hesitancy among U.S. Medicare beneficiaries. J Am Geriatr Soc 70:677–680.
- 15. Anand P, Stahel VP. 2021. The safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg 15:20.
- 16. Donnelly SC. 2022. COVID-19 vaccine hesitancy after side effects to the first vaccine: what are our options? QJM: An International Journal of Medicine. Oxford University Press.
- 17. Paris C, Bénézit F, Geslin M, Polard E, Baldeyrou M, Turmel V, Tadié É, Garlantezec R, Tattevin P. 2021. COVID-19 vaccine hesitancy among healthcare workers. Infect Dis Now 51:484–487.
Details
| Primary Language | English |
|---|---|
| Subjects | Clinical Sciences, Internal Diseases, Primary Health Care |
| Journal Section | Research Articles |
| Authors | |
| Publication Date | July 1, 2024 |
| Submission Date | December 27, 2022 |
| Published in Issue | Year 2024Volume: 15 Issue: 3 |
